This article provides a comprehensive analysis of premenstrual exacerbation (PME), the cyclical worsening of underlying psychiatric disorders during the luteal menstrual phase.
Accurate determination of the Limit of Quantitation (LOQ) is critical for ensuring the reliability of hormone assays in research and drug development.
This article provides a critical analysis for researchers and drug development professionals on the use of immunoassay kits for hormone quantification in serum and plasma.
This article provides a comprehensive framework for researchers and drug development professionals on integrating intermenstrual bleeding (IMB) into menstrual cycle calculations and clinical trial analyses.
This article provides a foundational and methodological guide for researchers and scientists on integrating hormone detection into field-based sports research.
This article provides a comprehensive analysis of luteal phase progesterone testing for researchers and drug development professionals.
This article addresses the critical methodological challenge of defining standardized hormonal boundaries for menstrual cycle phase determination, a cornerstone for reliable research in women's health and drug development.
This article synthesizes current evidence on follicular and luteal phase length variability, challenging the long-held assumption of a fixed 14-day luteal phase.
This article synthesizes current evidence on the high prevalence of anovulatory cycles and luteal phase deficiencies in exercising females, a critical issue often masked by regular menstrual bleeding.
This article provides a comprehensive review of the validation frameworks for non-invasive techniques used to assess long-term hormonal tissue exposure.